ارتباط شواهد استاتین برای حمایت از تصمیم گیری به اشتراک گذاشته شده
Communicating statin evidence to support shared decision-making
نویسندگان |
این بخش تنها برای اعضا قابل مشاهده است ورودعضویت |
اطلاعات مجله |
Barrettet al. BMC Family Practice (2016) 17:41 DOI 10.1186/s12875-016-0436-9 |
سال انتشار |
2016 |
فرمت فایل |
PDF |
کد مقاله |
19374 |
پس از پرداخت آنلاین، فوراً لینک دانلود مقاله به شما نمایش داده می شود.
چکیده (انگلیسی):
Background:The practice of clinical medicine rests on a foundation of ethical principles as well as scientific
knowledge. Clinicians must artfully balance the principle ofbeneficence, doing what is best for patients, with
autonomy, allowing patients to make their own well-informed health care decisions. The clinical communication
process is complicated by varying degrees of confidence in scientific evidence regarding patient-oriented benefits,
and by the fact that most medical options are associated with possible harms as well as potential benefits.
Discussion:Evidence-based clinical guidelines often neglect patient-oriented issues involved with the thoughtful
practice of shared decision-making, where individual values, goals, and preferences should be prioritized. Guidelines
on the use of statin medications for preventing cardiovascular events are a case in point. Current guidelines
endorse the use of statins for people whose 10-year risk of cardiovascular events is as low as 7.5 %. Previous
guidelines set the 10-year risk benchmark at 20 %. Meta-analysis of randomized trials suggests that statins can
reduce cardiovascular event rates by about 25 %, bringing 10-year risk from 7.5 to 5.6 %, for example, or from 20 to
15 %. Whether or not these benefits should justify the use of statins for individual patients depends on how those
advantages are valued in comparison with disadvantages, such as side effect risks, and with inconveniences
associated with taking a pill each day and visiting clinicians and laboratories regularly.
Conclusions:Whether or not the overall benefit-harm balance justifies the use of a medication for an individual
patient cannot be determined by a guidelines committee, a health care system, or even the attending physician.
Instead, it is the individual patient who has a fundamental right to decide whether or not taking a drug is
worthwhile. Researchers and professional organizations should endeavor to develop shared decision-making tools
that provide up-to-date best evidence in easily understandable formats, so as to assist clinicians in helping their
patients to make the decisions that are right for them.
کلمات کلیدی مقاله (فارسی):
گرش به سلامت، کلسترول، اهمیت بالینی، تحلیل هزینه-فایده، تصمیم گیری مبتنی بر شواهد پزشکی، دستورالعمل ها، لیپیدها، تفاوت مهم حداقل، نتایج، ترجیح بیمار، قلب و عروق پیشگیری، مراقبت های اولیه، کیفیت زندگی، مشترک تصمیم گیری، استاتین ها
کلمات کلیدی مقاله (انگلیسی):
Keywords:Attitude to health, Cholesterol, Clinical significance, Cost-benefit analysis, Decision making, Evidence-based medicine, Guidelines, Lipids, Minimal important difference, Outcomes, Patient preference, Preventive cardiology, Primary care, Quality of life, Shared decision-making, Statins
پس از پرداخت آنلاین، فوراً لینک دانلود مقاله به شما نمایش داده می شود.